Co-administration of biocompatible self-assembled polylactic acid–hyaluronic acid block copolymer nanoparticles with tumor-penetrating peptide-iRGD for metastatic breast cancer therapy-Reference-Cited by-同舟云学术

Co-administration of biocompatible self-assembled polylactic acid–hyaluronic acid block copolymer nanoparticles with tumor-penetrating peptide-iRGD for metastatic breast cancer therapy

Published:2018 Issue:19 Volume:6 Page:3163-3180
ISSN:2050-750X
Container-title:Journal of Materials Chemistry B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Deng Caifeng¹²³⁴⁵,Xu Xiaohong¹²³⁴,Tashi Drunp⁶⁷⁸⁴,Wu Yongmei⁹¹⁰¹¹²³,Su Bingyin⁹¹⁰¹¹²³,Zhang Quan¹²³⁴^ORCID

Affiliation:

1. School of Pharmacy

2. Chengdu Medical College

3. Chengdu 610500

4. China

5. Key Laboratory of Drug Targeting and Drug Delivery Systems

6. School of Tibetan Medicine

7. Qinghai University

8. Xining 810016

9. Development and Regeneration Key Lab of Sichuan Province

10. Department of Pathology

11. Department of Anatomy and Histology and Embryology

Abstract

The safe and efficient targeted delivery of chemotherapeutic drugs has remained a challenge in metastatic breast cancer therapy.

Funder

National Natural Science Foundation of China

Education Department of Sichuan Province

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering,General Chemistry,General Medicine

Link

http://pubs.rsc.org/en/content/articlepdf/2018/TB/C8TB00319J

Reference66 articles.

1. Hereditary breast and ovarian cancer: review and future perspectives

2. Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World

3. Breast cancer statistics, 2013

4. Inducing Optimal Antitumor Immune Response through Coadministering iRGD with Pirarubicin Loaded Nanostructured Lipid Carriers for Breast Cancer Therapy

5. Pharmacologic Sensitivity of Paclitaxel to Its Delivery Vehicles Drives Distinct Clinical Outcomes of Paclitaxel Formulations

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineering hyaluronic acid-based nanoassemblies for monoclonal antibody delivery – design, characterization, and biological insights;Nano Research;2024-07-11

2. Tumor–homing peptide iRGD-conjugate enhances tumor accumulation of camptothecin for colon cancer therapy;European Journal of Medicinal Chemistry;2024-02

3. Optimizing Enzyme-Responsive Polymersomes for Protein-Based Therapies;Nanomedicine;2024-01-25

4. Synthetic Routes to Hydrogels and Polysaccharide-Based Block Copolymers;ACS Symposium Series;2023-10-16

5. Recent advances in the tumor‐penetrating peptide internalizing RGD for cancer treatment and diagnosis;Drug Development Research;2023-04-05